Mr James Barri > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Mr James Barri
Position
Partner / Co-Chair Capital Markets and Debt Capital Markets
Career
James Barri is a partner, Co-Chair of the Capital Markets practice and Co-Chair of the Debt Capital Markets practice. Mr. Barri works on a variety of corporate and securities matters, including public and private offerings of debt and equity securities, tender and exchange offers, securities law compliance for public and private companies and other general corporate matters.
Education
J.D., 2001 Georgetown University Law Center (cum laude) / B.A., 1998 Cornell University
Lawyer Rankings
United States > Finance > Capital markets: debt offerings
Goodwin remains best known for its fervent activities in convertible debt for life sciences and tech businesses, particularly NYSE and Nasdaq-listed companies. It has an established record in convertible debt and related derivatives transactions. The firm also has a buoyant presence in investment grade and high-yield debt, and is well-versed in liability management transactions. Key figure, James Barri is co-chair of the capital markets team and has an outstanding reputation in convertible debt offerings. Fellow co-chair Ettore Santucci
is noted for REITs and real estate sector offerings. New York partner John Servidio has a long-term experience in convertible debt and related derivatives transactions. Named partners are based in Boston unless stated otherwise.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)